Les Sulewski
Stock Analyst at Truist Securities
(1.23)
# 3,738
Out of 5,150 analysts
18
Total ratings
56.25%
Success rate
-11.75%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Les Sulewski
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $15 → $17 | $13.30 | +27.82% | 4 | Mar 2, 2026 | |
| TEVA Teva Pharmaceutical Industries | Maintains: Buy | $38 → $42 | $32.91 | +27.62% | 3 | Feb 18, 2026 | |
| BHC Bausch Health Companies | Maintains: Hold | $7 → $8 | $5.63 | +42.10% | 1 | Jan 7, 2026 | |
| PCRX Pacira BioSciences | Maintains: Buy | $30 → $28 | $22.86 | +22.48% | 7 | Nov 7, 2025 | |
| COLL Collegium Pharmaceutical | Maintains: Buy | $45 → $48 | $39.61 | +21.18% | 3 | Nov 7, 2025 |
Amneal Pharmaceuticals
Mar 2, 2026
Maintains: Buy
Price Target: $15 → $17
Current: $13.30
Upside: +27.82%
Teva Pharmaceutical Industries
Feb 18, 2026
Maintains: Buy
Price Target: $38 → $42
Current: $32.91
Upside: +27.62%
Bausch Health Companies
Jan 7, 2026
Maintains: Hold
Price Target: $7 → $8
Current: $5.63
Upside: +42.10%
Pacira BioSciences
Nov 7, 2025
Maintains: Buy
Price Target: $30 → $28
Current: $22.86
Upside: +22.48%
Collegium Pharmaceutical
Nov 7, 2025
Maintains: Buy
Price Target: $45 → $48
Current: $39.61
Upside: +21.18%